Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Tumor Biology
Published in: Tumor Biology 12/2016

01-12-2016 | Original Article

MiR-212/132 is epigenetically downregulated by SOX4/EZH2-H3K27me3 feedback loop in ovarian cancer cells

Authors: Lin Lin, Zhiwen Wang, Haihong Jin, Hongzhen Shi, Zhihong Lu, Zhenqin Qi

Published in: Tumor Biology | Issue 12/2016

Login to get access

Abstract

Both miR-212 and miR-132 are usually downregulated in ovarian cancer and act as tumor suppressors. However, the mechanism of their downregulation in ovarian cancer is not clear. In this study, we investigated the regulative effects of miR-212 and miR-132 on SOX4 expression in ovarian cancer cells and also studied whether there is a feedback regulation between miR-212/miR-132 and SOX4 via an epigenetic mechanism. The results showed that both EZH2 and SOX4 overexpressions significantly repressed miR-212 and miR-132 expressions in SKOV3 and OV2008 cells. Immunoprecipitation assay showed that there are interactions among SOX4, EZH2, and H3K27me3, and ChIP assay confirmed significant enrichment of EZH2 and H3K27me3 in the promoter region of miR-212/132. Both pri-miR-212 and pri-miR-132 expressions decreased after enforced EZH2 or SOX4 expression. Western blot and dual-luciferase assay confirmed that miR-212 and miR-132 can target the same sites in the 3′UTR of SOX4 mRNA and suppress its expression in ovarian cancer cells. MiR-132 or miR-212 overexpression or knockdown of endogenous SOX4 reduced epithelial-mesenchymal transition (EMT)-like properties. Therefore, we infer that the SOX4/EZH2 complex can silence miR-212 and miR-132 expressions via binding to the promoter region and promoting H3K27me3, while miR-212 and miR-132 can directly bind to the 3′UTR of SOX4 and suppress its expression. This forms a MiR-132/212-SOX4/EZH2-H3K27me3 feedback loop in ovarian cancer cells. Functionally, SOX4 is a downstream effector of miR-212/132 modulating EMT of ovarian cancer cells.
Literature
1.
Shao C, Lacey M, Dubeau L, Ehrlich M. Hemimethylation footprints of DNA demethylation in cancer. Epigenetics. 2009;4:165–75.CrossRefPubMed
2.
Chmelarova M, Krepinska E, Spacek J, Laco J, Beranek M, Palicka V. Methylation in the p53 promoter in epithelial ovarian cancer. Clinical & translational oncology: official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2013;15:160–3.CrossRef
3.
Zaman MS, Maher DM, Khan S, Jaggi M, Chauhan SC. Current status and implications of microRNAs in ovarian cancer diagnosis and therapy. Journal of ovarian research. 2012;5:44.CrossRefPubMedPubMedCentral
4.
Nakahama T, Hanieh H, Nguyen NT, Chinen I, Ripley B, Millrine D, Lee S, Nyati KK, Dubey PK, Chowdhury K, Kawahara Y, Kishimoto T. Aryl hydrocarbon receptor-mediated induction of the microrna-132/212 cluster promotes interleukin-17-producing T-helper cell differentiation. Proc Natl Acad Sci U S A. 2013;110:11964–9.CrossRefPubMedPubMedCentral
5.
Tian H, Hou L, Xiong YM, Huang JX, Zhang WH, Pan YY, Song XR. Mir-132 targeting e2f5 suppresses cell proliferation, invasion, migration in ovarian cancer cells. Am J Transl Res. 2016;8:1492–501.PubMedPubMedCentral
6.
Chung YW, Bae HS, Song JY, Lee JK, Lee NW, Kim T, Lee KW. Detection of microrna as novel biomarkers of epithelial ovarian cancer from the serum of ovarian cancer patients. International journal of gynecological cancer: official journal of the International Gynecological Cancer Society. 2013;23:673–9.CrossRef
7.
Wei LQ, Liang HT, Qin DC, Jin HF, Zhao Y, She MC. Mir-212 exerts suppressive effect on skov3 ovarian cancer cells through targeting HBEGF. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2014;35:12427–34.CrossRef
8.
Vire E, Brenner C, Deplus R, Blanchon L, Fraga M, Didelot C, Morey L, Van Eynde A, Bernard D, Vanderwinden JM, Bollen M, Esteller M, Di Croce L, de Launoit Y, Fuks F. The polycomb group protein ezh2 directly controls DNA methylation. Nature. 2006;439:871–4.CrossRefPubMed
9.
Cao R, Zhang Y. The functions of e(z)/ezh2-mediated methylation of lysine 27 in histone h3. Current opinion in genetics & development. 2004;14:155–64.CrossRef
10.
Wang B, Liu Y, Luo F, Xu Y, Qin Y, Lu X, Xu W, Shi L, Liu Q, Xiang Q. Epigenetic silencing of microrna-218 via ezh2-mediated h3 k27 trimethylation is involved in malignant transformation of hbe cells induced by cigarette smoke extract. Arch Toxicol. 2016;90:449–61.CrossRefPubMed
11.
Koumangoye RB, Andl T, Taubenslag KJ, Zilberman ST, Taylor CJ, Loomans HA, Andl CD. Sox4 interacts with ezh2 and hdac3 to suppress microRNA-31 in invasive esophageal cancer cells. Mol Cancer. 2015;14:24.CrossRefPubMedPubMedCentral
12.
Chung VY, Tan TZ, Tan M, Wong MK, Kuay KT, Yang Z, Ye J, Muller J, Koh CM, Guccione E, Thiery JP, Huang RY. Grhl2-mir-200-zeb1 maintains the epithelial status of ovarian cancer through transcriptional regulation and histone modification. Scientific reports. 2016;6:19943.CrossRefPubMedPubMedCentral
13.
Bowles J, Schepers G, Koopman P. Phylogeny of the sox family of developmental transcription factors based on sequence and structural indicators. Dev Biol. 2000;227:239–55.CrossRefPubMed
14.
Yeh YM, Chuang CM, Chao KC, Wang LH. MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis by targeting sox4 and hif-1alpha. Int J Cancer. 2013;133:867–78.CrossRefPubMed
15.
Jin Y, Zhao M, Xie Q, Zhang H, Wang Q, Ma Q. MicroRNA-338-3p functions as tumor suppressor in breast cancer by targeting sox4. Int J Oncol. 2015;47:1594–602.PubMed
16.
Tiwari N, Tiwari VK, Waldmeier L, Balwierz PJ, Arnold P, Pachkov M, Meyer-Schaller N, Schubeler D, van Nimwegen E, Christofori G. Sox4 is a master regulator of epithelial-mesenchymal transition by controlling ezh2 expression and epigenetic reprogramming. Cancer Cell. 2013;23:768–83.CrossRefPubMed
17.
18.
Xu L, Wang F, XF X, Mo WH, Xia YJ, Wan R, Wang XP, Guo CY. Down-regulation of mir-212 expression by DNA hypermethylation in human gastric cancer cells. Med Oncol. 2011;28(Suppl 1):S189–96.CrossRefPubMed
19.
Formosa A, Lena AM, Markert EK, Cortelli S, Miano R, Mauriello A, Croce N, Vandesompele J, Mestdagh P, Finazzi-Agro E, Levine AJ, Melino G, Bernardini S, Candi E. DNA methylation silences mir-132 in prostate cancer. Oncogene. 2013;32:127–34.CrossRefPubMed
20.
Liu X, Dong R, Jiang Z, Wei Y, Li Y, Wei L, Sun H, Li Y, Yang N, Yang Q, Liu Z, Kong B. Mdc1 promotes ovarian cancer metastasis by inducing epithelial-mesenchymal transition. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2015;36:4261–9.CrossRef
21.
Incoronato M, Urso L, Portela A, Laukkanen MO, Soini Y, Quintavalle C, Keller S, Esteller M, Condorelli G. Epigenetic regulation of mir-212 expression in lung cancer. PLoS One. 2011;6:e27722.CrossRefPubMedPubMedCentral
22.
Wei X, Tan C, Tang C, Ren G, Xiang T, Qiu Z, Liu R, Wu Z. Epigenetic repression of mir-132 expression by the hepatitis B virus × protein in hepatitis B virus-related hepatocellular carcinoma. Cell Signal. 2013;25:1037–43.CrossRefPubMed
23.
Vella S, Pomella S, Leoncini PP, Colletti M, Conti B, Marquez VE, Strillacci A, Roma J, Gallego S, Milano GM, Capogrossi MC, Bertaina A, Ciarapica R, Rota R. MicroRNA-101 is repressed by ezh2 and its restoration inhibits tumorigenic features in embryonal rhabdomyosarcoma. Clinical epigenetics. 2015;7:82.CrossRefPubMedPubMedCentral
24.
Liu L, Guo J, Yu L, Cai J, Gui T, Tang H, Song L, Wang J, Han F, Yang C, Chen C, Marks A, Wang Z. Mir-101 regulates expression of ezh2 and contributes to progression of and cisplatin resistance in epithelial ovarian cancer. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2014;35:12619–26.CrossRef
25.
Liu Y, Li Y, Liu J, Wu Y, Zhu Q. MicroRNA-132 inhibits cell growth and metastasis in osteosarcoma cell lines possibly by targeting sox4. Int J Oncol. 2015;47:1672–84.PubMedPubMedCentral
26.
Li Y, Zu L, Wang Y, Wang M, Chen P, Zhou Q. Mir-132 inhibits lung cancer cell migration and invasion by targeting sox4. Journal of thoracic disease. 2015;7:1563–9.PubMedPubMedCentral
27.
Mehta A, Mann M, Zhao JL, Marinov GK, Majumdar D, Garcia-Flores Y, Du X, Erikci E, Chowdhury K, Baltimore D. The microRNA-212/132 cluster regulates b cell development by targeting sox4. J Exp Med. 2015;212:1679–92.CrossRefPubMedPubMedCentral
28.
Hu F, Min J, Cao X, Liu L, Ge Z, Hu J, Li X. Mir-363-3p inhibits the epithelial-to-mesenchymal transition and suppresses metastasis in colorectal cancer by targeting sox4. Biochem Biophys Res Commun. 2016;474:35–42.CrossRefPubMed
29.
Li S, Qin X, Li Y, Zhang X, Niu R, Zhang H, Cui A, An W, Wang X. Mir-133a suppresses the migration and invasion of esophageal cancer cells by targeting the emt regulator sox4. Am J Transl Res. 2015;7:1390–403.PubMedPubMedCentral
Metadata
Title
MiR-212/132 is epigenetically downregulated by SOX4/EZH2-H3K27me3 feedback loop in ovarian cancer cells
Authors
Lin Lin
Zhiwen Wang
Haihong Jin
Hongzhen Shi
Zhihong Lu
Zhenqin Qi
Publication date
01-12-2016
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 12/2016
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-016-5339-9

Other articles of this Issue 12/2016

Tumor Biology 12/2016 Go to the issue

Review

The roles of microRNAs related with progression and metastasis in human cancers

Original Article

Ski modulate the characteristics of pancreatic cancer stem cells via regulating sonic hedgehog signaling pathway

Original Article

FAT4 functions as a tumor suppressor in triple-negative breast cancer

Original Article

RETRACTED ARTICLE: miR-203 suppression in gastric carcinoma promotes Slug-mediated cancer metastasis

Retraction Note

Retraction Note to: Downregulation of miR-185 and upregulation of miR-218 expression may be potential diagnostic and prognostic biomarkers of human chondrosarcoma

Review

Lapatinib resistance in HER2+ cancers: latest findings and new concepts on molecular mechanisms
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits